Related Experiment Video
Updated: Aug 14, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15
Kathy King1, Mohammed F Sheikh, Andrew P Cuthbert
1Department of Medical and Molecular Genetics, Guy's, King's and St. Thomas' School of Medicine, King's College London, London, United Kingdom.
Insights
This study investigated CARD15 (NOD2) gene mutations in Crohn disease (CD). Most CD patients heterozygous for common mutations are true heterozygotes, supporting a gene dosage model for CD susceptibility.
Area of Science:
- Genetics
- Molecular Biology
- Gastroenterology
Background:
- Three common CARD15 (NOD2) gene mutations are linked to Crohn disease (CD) susceptibility, suggesting a gene dosage model.
- The existence of rare CARD15 variants raises questions about recessive models for CD in heterozygotes carrying common mutations.
Purpose of the Study:
- To investigate whether heterozygotes for common CARD15 mutations also carry rare pathogenic variants, which would impact CD genetic models.
- To develop and apply a strategy for evaluating potential CARD15 disease susceptibility alleles (DSAs).
Main Methods:
- Screened CARD15 for mutations in 100 CD patients heterozygous for common mutations.
- Assessed evolutionary conservation of CARD15 residues by sequencing orthologs in primates and other species.
- Evaluated predicted protein structure/function effects and genotyped potential DSAs in cases and controls.
Main Results:
- 11 out of 100 CD patients had a second potential pathogenic CARD15 mutation.
- Identified four novel nonsynonymous mutations, including one causing premature termination (c.2686C>T, p.Arg896X).
- Two potential DSAs (c.2107C>T, p.Arg703Cys and g.2238T>A, c.74-7T>A) were significantly associated with CD.
Conclusions:
- The findings support a gene dosage model for CD susceptibility, as most carriers of common CARD15 DSAs appear to be true heterozygotes.
- The study identified novel CARD15 mutations and potential DSAs associated with CD.
- A generalizable strategy for assessing mutation pathogenicity and genetic models in complex disorders was developed.
Abstract:
Three common mutations in the CARD15 (NOD2) gene are known to be associated with susceptibility to Crohn disease (CD), and genetic data suggest a gene dosage model with an increased risk of 2-4-fold in heterozygotes and 20-40-fold in homozygotes. However, the discovery of numerous rare variants of CARD15 indicates that some heterozygotes for the common mutations have a rare mutation on the other CARD15 allele, which would support a recessive model for CD. We addressed this issue by screening CARD15 for mutations in 100 CD patients who were heterozygous for one of the three common mutations. We also developed a strategy for evaluating potential disease susceptibility alleles (DSAs) that involves assessing the degree of evolutionary conservation of involved residues, predicted effects on protein structure and function, and genotyping in a large sample of cases and controls. The evolutionary analysis was aided by sequencing the entire coding region of CARD15 in three primates (chimp, gibbon, and tamarin) and aligning the human sequence with these and orthologs from other species. We found that 11 of the 100 CD patients screened had a second potential pathogenic mutation within the exonic and periexonic sequences examined. Assuming that there are no additional pathogenic mutations in noncoding regions, our study suggests that most carriers of the common DSAs are true heterozygotes, and supports previous evidence for a gene dosage model. Four novel nonsynonymous mutations were detected, one of which would produce premature termination of translation c.2686C>T (p.Arg896X). Two potential DSAs--c.2107C>T (p.Arg703Cys) and g.2238T>A (c.74-7T>A)--were significantly associated with CD in the case control sample. Analysis of the evolution of CARD15 revealed strong conservation of the encoded protein, with identity to the human sequence ranging from 99.1% in the chimp to 44.5% in fugu. Higher primates possess an open reading frame (ORF) upstream of the putative initiation site in other species that encodes a further 27 N-terminal amino acids, while four regions of high conservation are observed outside of the known domains of CARD15, indicative of additional residues of functional importance. The strategy developed here may have general application to the assessment of mutation pathogenicity and genetic models in other complex disorders.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Evolution of New Traits in Microbes
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
